Ms. Klobuchar (for herself and Mr. Wicker) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Scientific External Process for Educated Review of Therapeutics Act of 2025. S. 822. 119th
Cong., 1st
sess., Introduced in Senate March 3, 2025. https://www.govinfo.gov/app/details/BILLS-119s822is.
APA
Congress, Senate (2025, March 3). Scientific External Process for Educated Review of Therapeutics Act of 2025 (S. 822 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s822is.
MLA
United States, Congress, Senate. Scientific External Process for Educated Review of Therapeutics Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s822is. 119th Congress, S. 822, Introduced in Senate 3 Mar. 2025.
Bluebook
S.822 - 119th Congress (2025-2026): Scientific External Process for Educated Review of Therapeutics Act of 2025, S.822, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s822is.
